Adaptive Biotechnologies IPO: Five things to know - MarketWatch
Adaptive Biotechnologies: A Platform Play For Immune Driven Medicine (NASDAQ:ADPT) | Seeking Alpha
Adaptive Biotechnologies Shares Double After IPO - TheStreet
Forget Beyond Meat — Adaptive Biotechnologies just spiked 95% in its public trading debut, marking the year's best post-IPO pop (ADPT) | Markets Insider
Adaptive Biotechnologies Insider Trades $1.67 Million In Company Stock - Benzinga
Adaptive Biotechnologies Corp Stock Rating and Data | - GuruFocus.com